ERYTECH verkündet zuvor auf Jahrestagung der American Society of Hematology präsentierte positive Ergebnisse der Phase-II-Studie von Eryaspase bei akuter lymphoblastischer Leukämie

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Frank Burrell
Scientific Storytelling

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement